Results of the PI3K delta inhibitor ME-401 alone or with rituximab in relapsed/refractory (R/R) follicular lymphoma (FL) Journal Article


Authors: Zelenetz, A. D.; Jagadeesh, D.; Reddy, N. M.; Stathis, A.; Salman, H. S.; Asch, A. S.; Kenkre, V. P.; Jhangiani, H. S.; Iasonos, A.; Soumerai, J. D.; Llorin, J.; Pagel, J. M.
Article Title: Results of the PI3K delta inhibitor ME-401 alone or with rituximab in relapsed/refractory (R/R) follicular lymphoma (FL)
Journal Title: Journal of Clinical Oncology
Volume: 37
Issue: 15
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2019-05-01
Language: English
ACCESSION: WOS:000487345806274
PROVIDER: wos
Notes: Meeting Abstract -- Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) -- MAY 31-JUN 04, 2019 -- Chicago, IL -- S -- Source: Wos